Earle A. Chiles Research Institute

  • Shorter treatment duration with new therapy is focus of rectal cancer trial

    Shorter treatment duration with new therapy is focus of rectal cancer trial

    New Providence-sponsored study may provide new insights into the efficacy of shorter duration radiation and chemotherapy treatment before surgery for people with stage II/III rectal cancer

    Read Article
  • Multi-indication clinical trials help evaluate new medications for future treatments

    Multi-indication clinical trials help evaluate new medications for future treatments

    Two early phase trials testing the safety and tolerability of new medications may help people with sarcomas, lymphomas and other cancers.

    Read Article
  • Research lab focuses on improving treatments for soft tissue sarcoma

    Research lab focuses on improving treatments for soft tissue sarcoma

    Dr. Jianguo Huang to lead the Preclinical Cancer Therapy Laboratory with a focus on bridging sarcoma research and immunotherapy

    Read Article
  • Earle A. Chiles Research Institute scientist awarded K22 to develop new lab

    Earle A. Chiles Research Institute scientist awarded K22 to develop new lab

    Providence researcher awarded National Institutes of Health grant to lead a new lab focusing on the discovery of novel inflammatory pathways in cancer that are targets for therapeutic intervention.

    Read Article
  • Two studies assess combination treatments for advanced breast cancers

    Two studies assess combination treatments for advanced breast cancers

    Two investigator-initiated trials sponsored by the Earle A. Chiles Research Institute are currently recruiting patients with either advanced HER2-positive or HR positive/HER2 negative breast cancer.

    Read Article
  • Documentary film features Providence patients, researchers in pursuit of revolutionary cancer therapy

    Documentary film features Providence patients, researchers in pursuit of revolutionary cancer therapy

    "Within Reach: The Fight to Finish Cancer" follows patient participants and teams of researchers and clinicians at Providence Cancer Institute working to create a living drug for incurable cancers.

    Read Article
  • Clinical trials: Leading breakthroughs in cancer research

    Clinical trials: Leading breakthroughs in cancer research

    May 20 is International Clinical Trials Day. Clinical trials are evidence-based studies in people that result in the biggest breakthroughs in cancer research.

    Read Article
  • Studies will evaluate combination therapies for two types of melanoma

    Studies will evaluate combination therapies for two types of melanoma

    Two new clinical trials available at Providence will evaluate whether a combination of medications are effective and safe therapies for people with metastatic melanoma and metastatic uveal melanoma.

    Read Article
  • New study evaluates immunoradiotherapy treatment for head and neck cancer patients

    New study evaluates immunoradiotherapy treatment for head and neck cancer patients

    Investigator-initiated clinical trial at Providence Cancer Institute to evaluate the safety and efficacy of using a combination of immunotherapy and radiation therapy on tumors.

    Read Article
  • Study to evaluate effect of immunotherapy in blood cancer

    Study to evaluate effect of immunotherapy in blood cancer

    A new phase I clinical trial available at Providence Cancer Institute of Oregon will evaluate the efficacy of new immunotherapy designed to modulate the immune system in blood cancer patients.

    Read Article
  • Three studies concentrate on personalized treatment for colon cancer

    Three studies concentrate on personalized treatment for colon cancer

    Clinical studies focus on finding new ways to treat colorectal cancer, prevent recurrence and improve survival outcomes.

    Read Article
  • Three studies focus on improving treatments for gastrointestinal cancers

    Three studies focus on improving treatments for gastrointestinal cancers

    People with gallbladder cancer, bile duct cancer or pancreatic cancer may be eligible to participate in new clinical trials available at Providence Cancer Institute of Oregon.

    Read Article
  • Clinical trial aims to help premenopausal women at risk for ovarian cancer

    Clinical trial aims to help premenopausal women at risk for ovarian cancer

    Researchers at Providence Cancer Institute are studying how well two surgical procedures work in reducing the risk of ovarian cancer for women with BRCA1 mutations.

    Read Article
  • New clinical study for people with advanced or metastatic lung cancer

    New clinical study for people with advanced or metastatic lung cancer

    A new study at Providence Cancer Institute tests the effectiveness of an experimental treatment and chemotherapy to inhibit tumor growth in people with lung cancer.

    Read Article
  • New clinical studies for invasive breast cancer

    New clinical studies for invasive breast cancer

    Providence Cancer Institute breast cancer experts are researching new treatments for women with triple-negative breast cancer and HER-2 positive breast cancer.

    Read Article
  • New research laboratory employs biomedical engineering for precision cancer surgery

    New research laboratory employs biomedical engineering for precision cancer surgery

    Experts in biomedical engineering, immunology and surgical oncology are working collaboratively to improve outcomes for people with head, neck and other cancers.

    Read Article
  • CAR T-cell therapy for advanced kidney cancer

    CAR T-cell therapy for advanced kidney cancer

    Providence Cancer Institute to open new clinical study of CAR T-cell therapy to people with clear cell renal cell carcinoma, the most common type of kidney cancer.

    Read Article
  • First-in-human immune therapy study for multiple myeloma

    First-in-human immune therapy study for multiple myeloma

    First-in-human immune therapy study at Providence Cancer Institute will assess the safety and effectiveness of talquetamab as a potential treatment for cancerous plasma cells known as multiple myeloma

    Read Article
  • Federal grant fuels research in harnessing micro-organisms for cancer immunotherapy

    Federal grant fuels research in harnessing micro-organisms for cancer immunotherapy

    Providence researchers awarded funding from National Cancer Institute to study “Bugs as Drugs.”

    Read Article
  • Can photo-immunotherapy improve outcomes in advanced solid tumors?

    Can photo-immunotherapy improve outcomes in advanced solid tumors?

    Providence Cancer Institute to offer a new phase I/II study of a first-in-class photoimmunotherapy for solid tumors that overexpress the epidermal growth factor receptor protein.

    Read Article
  • loading
    Loading More...